Author
Rob Harley
Cannabis policy & news writer for Cannabivo
Rob Harley has reported on cannabis law and the non-profit association movement across Europe for the past decade. He focuses on how regulation actually reaches the members who use cannabis social clubs — the paperwork, the limits, and the slow build of public trust. His work for Cannabivo aims to be accurate, sourced, and free of hype.
View member profileLatest articles
Ananda Pharma’s ACTiON Trial Enters Phase 2 After First UK Patient Dose
Ananda Pharma has dosed the first patient in the UK’s NIHR-backed ACTiON Phase 2 trial testing CBD-based MRX1 for chemotherapy-induced neuropathy.
Switzerland’s St. Gallen Pilot Puts Fetterman’s Call for US Marijuana Legalization in Context
Switzerland’s St. Gallen pilot frames the policy contrast as US Sen. John Fetterman urges Congress to end federal cannabis prohibition.
Ananda Pharma Doses First Patient in UK NIHR-Backed CIPN Trial
Ananda Pharma has dosed the first patient in the UK’s NIHR-backed ACTiON Phase 2 trial of CBD-based MRX1 for chemotherapy-induced neuropathy.
Malta’s Cannabis Network Reaches Eight as Study Warns Tax Hikes Can Push Consumers to Unregulated Markets
Malta’s regulated cannabis network has reached eight licensed associations as a US study finds tax-driven price rises can shift consumers to unregulated
Trichomes Are the Key to Potent Cannabis Flowers, Study Finds
A University of British Columbia study links frosty cannabis flowers to cannabinoids and terpenes, showing why trichomes matter for potency and aroma.
Germany's GKV cannabis cut draws DHV backlash over reimbursement
Germany’s DHV says a Bundestag-Bundesrat vote cut GKV reimbursement for cannabis flowers and early-stage medical cannabis treatments.
Germany’s BLE approves four cannabis research projects, but keeps consumer trials out
Germany’s BLE has approved four cannabis research projects and kept consumer trials out, based on application data from late 2024 to 2025.
Germany: THC Cannabis Beverages Are Helping Some Users Quit Alcohol, Survey Shows
Germany: a THC beverage customer survey found many users drink less alcohol or quit entirely, adding a new signal to cannabis policy debate.
How Much THC Is in the Blood After One Joint in Germany?
Germany’s 3.5 ng/ml THC limit meets a fast blood spike: what one joint can show, how long it lasts, and why serum matters.
Germany’s biggest cannabis club still has 18,000 members — and no cannabis yet
Germany’s biggest cannabis club has 18,000 members, 180 branches and only one licence, leaving many members waiting after a year.
Cannabis and sport: when THC slows training and CBD may help recovery
THC can raise heart rate and slow reactions, while CBD may aid recovery. Here’s what sport science and anti-doping rules actually say.
Cannabis Overdose: How Long Does a Greenout Last, and What Helps?
A greenout is usually temporary. This explainer shows how long cannabis overdose symptoms last, what helps in the moment, and why edibles linger.
How Germany determines the price of a cannabis finished medicinal product
Germany lets manufacturers set a launch price for six months, then AMNOG, the G-BA and GKV talks shape the reimbursement amount for finished medicinal cannabis.
European Union: UK Medical Cannabis Market Is Growing Faster Than Expected
UK imports topped 30,000 kg in 2025, products doubled and Prohibition Partners sees 40,000+ more patients by end-2026.
UK Medical Cannabis Patients Set to Pass 140,000 in 2026, Report Says
Prohibition Partners says UK medical cannabis patients could top 140,000 in 2026 as imports, product choice and private teleclinics expand.
Why Patients Feel Lost in Cannabinoid Medicine: Chronic Symptoms, Mixed Advice and the Search for Better Answers
Patients entering cannabinoid medicine face mixed advice, variable effects and incomplete evidence. This is why so many still feel lost.
Germany’s KCanG evaluation: what two years of partial cannabis legalisation changed
Germany’s second KCanG review finds modest gains, stable youth-use indicators, weak club uptake, and a medical cannabis market expanding fastest.
European Union medical cannabis trade: Germany’s 50-tonne quarter shows a market still built on imports
In the European Union, Germany imported 50.539 tonnes of medical cannabis in Q1 2026, showing the scale and shifting structure of the bloc’s biggest market.
EU medical cannabis market: Germany imported more than 50 tonnes in Q1 2026
EU medical cannabis still runs through Germany: imports topped 50 tonnes in Q1 2026, even as quarterly volumes dipped for the first time in two years.
Germany Watches Bilbao as Spannabis 2026 Opens a New Chapter for Europe’s Cannabis Industry
Why Bilbao’s first Spannabis mattered to Germany and Europe: 20,000+ visitors, Spain’s new medical cannabis rules and a changing fair map.
European Union medical cannabis trade: Germany imported more than 50 tonnes in Q1 2026
European Union market watch: Germany imported 50.539 tonnes of medical cannabis in Q1 2026, despite a quarterly dip.
Germany: What the KCanG evaluation shows two years after partial cannabis legalisation
Germany's second KCanG interim review: no surge in use, more home cultivation, a weak club role and a fast-growing medical cannabis market nationwide so far.
European Union drug map: cocaine routes, vapes and fake medicines reshape the market
The European Union’s Drug Report 2026 shows cocaine moving through ports and labs as vapes, fake medicines and new synthetics complicate control.
Germany: Four States Publish Cannabis Social Club Lists as CSC Rollout Turns to Transparency
Germany’s CSC rollout gains visibility as Berlin, Hamburg, Lower Saxony and Rhineland-Palatinate publish cannabis social club lists.
Germany’s interior ministers push to ban public cannabis consumption again
Germany’s state interior ministers want public cannabis consumption banned again and may seek limits on cannabis clubs at talks in Hamburg.
Germany: cannabis-related driving crashes should be counted in official statistics
Germany should include cannabis-related driving accidents in crash statistics, a move supporters say would clarify road-safety risks.
DHV warns Germany’s draft GKV savings law could raise costs, not cut them
The DHV says a draft GKV savings law would end reimbursement for cannabis flowers and could increase medical costs instead.
Cannabis Edibles Dosage: How to Avoid Overdosing
Edibles can be easy to misjudge. Here’s how to reduce overdose risk with timing, dosing discipline, and safer handling.
Is cannabis legal in Europe? The answer depends on where, and how, you ask
Europe has no single cannabis law. EU states are splitting on medical use, adult-use reform, and tighter drug controls.
Ananda Pharma says MRX1 CBD drug clears safety hurdle as pain trials near
Ananda Pharma has released MRX1 safety data as it prepares clinical pain trials for its CBD oral solution.